"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk ...

SOME 82 Brits have died after using weight-loss and diabetes jabs such as Ozempic and Mounjaro. The official figures from the ...

The Medicines and Healthcare products Regulatory Agency issued an alert as a crackdown on prescriptions was underway ...

Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.

At least 82 Brits are known to have died after taking weight-loss drugs such as Ozempic and Mounjaro. The Medicines and ...

Medical treatments, including jabs used for weight loss, are monitored in part using the Medicines and Healthcare products ...

The MHRA reveals a staggering rise in deaths linked to weight loss and diabetes medications in the UK, with concerns over ...

This launch follows the nod from the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA), making Biocon the ...

Biocon announced the launch of its GLP-1 peptide, Liraglutide, for diabetes and obesity, in the United Kingdom (U.K.). The drug-device combination will be marketed in the U.K. under the brand names ...